ZA200104146B - Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males. - Google Patents
Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males.Info
- Publication number
- ZA200104146B ZA200104146B ZA200104146A ZA200104146A ZA200104146B ZA 200104146 B ZA200104146 B ZA 200104146B ZA 200104146 A ZA200104146 A ZA 200104146A ZA 200104146 A ZA200104146 A ZA 200104146A ZA 200104146 B ZA200104146 B ZA 200104146B
- Authority
- ZA
- South Africa
- Prior art keywords
- apomorphine
- males
- medicament
- manufacture
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/213,567 US6291471B1 (en) | 1998-12-17 | 1998-12-17 | Use of apomorphine for the treatment of organic erectile dysfunction in males |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200104146B true ZA200104146B (en) | 2002-08-21 |
Family
ID=22795606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200104146A ZA200104146B (en) | 1998-12-17 | 2001-05-21 | Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males. |
Country Status (22)
Country | Link |
---|---|
US (1) | US6291471B1 (fr) |
EP (1) | EP1140094A1 (fr) |
JP (1) | JP2003521462A (fr) |
KR (1) | KR20010101241A (fr) |
CN (1) | CN1335772A (fr) |
AR (1) | AR021912A1 (fr) |
AU (1) | AU2175800A (fr) |
BG (1) | BG105664A (fr) |
BR (1) | BR9916114A (fr) |
CA (1) | CA2354601A1 (fr) |
CZ (1) | CZ20012084A3 (fr) |
HK (1) | HK1043303A1 (fr) |
HU (1) | HUP0201618A3 (fr) |
IL (1) | IL143410A0 (fr) |
NO (1) | NO20012985L (fr) |
NZ (1) | NZ511790A (fr) |
PL (1) | PL354920A1 (fr) |
SK (1) | SK8262001A3 (fr) |
TR (1) | TR200101719T2 (fr) |
TW (1) | TW577740B (fr) |
WO (1) | WO2000035457A1 (fr) |
ZA (1) | ZA200104146B (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566368B2 (en) * | 1994-04-22 | 2003-05-20 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
BR0005797A (pt) * | 2000-03-20 | 2001-10-16 | Abbott Lab | Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados |
WO2002041894A2 (fr) * | 2000-11-22 | 2002-05-30 | Abbott Laboratories | Utilisation d'agonistes selectifs des recepteur d4 de la dopamine dans le traitement de dysfonctions sexuelles |
AR032556A1 (es) * | 2001-02-08 | 2003-11-12 | Pharmacia Corp | Medicamento de accion inmediata para el tratamiento de la disfuncion sexual |
JP2005526790A (ja) * | 2002-03-19 | 2005-09-08 | ミシェル ホリック | アポモルフィンおよび類縁体の配糖体およびオルトエステル配糖体誘導体、ならびにそれらの使用方法 |
SE0202365D0 (sv) | 2002-08-05 | 2002-08-05 | Pharmacia Ab | New formulation and use thereof |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
CA2522231A1 (fr) * | 2003-04-14 | 2004-10-21 | Vectura Ltd | Compositions pharmaceutiques comprenant de l'apomorphine pour l'inhalation pulmonaire |
US7648995B2 (en) * | 2004-04-13 | 2010-01-19 | The Mclean Hospital Corporation | R(—)-11-hydroxyaporphine derivatives and uses thereof |
GB2437488A (en) * | 2006-04-25 | 2007-10-31 | Optinose As | Pharmaceutical oily formulation for nasal or buccal administration |
US8431591B2 (en) * | 2007-07-12 | 2013-04-30 | The Mclean Hospital Corporation | R(−)-2-methoxy-11-hydroxyaporphine and derivatives thereof |
BRPI0800596A2 (pt) | 2008-01-31 | 2009-09-22 | Univ Minas Gerais | método para a potencialização da função erétil através do uso das composições farmacêuticas de toxina tx2-6 da aranha phoneutria nigriventer |
PT2651357T (pt) | 2010-12-16 | 2020-06-17 | Sunovion Pharmaceuticals Inc | Películas sublinguais |
KR101374500B1 (ko) * | 2012-10-09 | 2014-03-13 | 울산대학교 산학협력단 | R(-)-프로필노르아포모르핀을 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
PT2981271T (pt) | 2013-04-05 | 2019-02-19 | Boehringer Ingelheim Int | Utilizações terapêuticas de empagliflozina |
US20140303097A1 (en) | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
CA2909728C (fr) | 2013-04-18 | 2022-12-06 | Boehringer Ingelheim International Gmbh | Utilisations therapeutiques de l'empagliflozine |
WO2016174155A1 (fr) * | 2015-04-30 | 2016-11-03 | Boehringer Ingelheim International Gmbh | Procédés et compositions pharmaceutiques comprenant un inhibiteur de sglt2 pour le traitement ou l'amélioration d'une dysérection |
WO2017168174A1 (fr) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | Nouvelles formes pharmaceutiques du sildénafil |
WO2019241585A1 (fr) * | 2018-06-14 | 2019-12-19 | Astrazeneca Uk Limited | Méthodes de traitement d'une dysfonction érectile avec une composition pharmaceutique d'inhibiteur de phosphodiestérase 5 spécifique de cgmp |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256652A (en) | 1987-11-12 | 1993-10-26 | Pharmedic Co. | Topical compositions and methods for treatment of male impotence |
US5270323A (en) | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
US5292520A (en) | 1990-09-13 | 1994-03-08 | Akzo N.V. | Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer |
DK0689438T3 (da) | 1993-03-26 | 2003-09-29 | Franciscus Wilhelmus He Merkus | Farmaceutiske præparater til intranasal administration af apomorfin |
DK0978282T3 (da) * | 1994-04-22 | 2006-04-10 | Pentech Pharmaceuticals Inc | Sublingualt præparat indeholdende apomorphin til diagnosticering af funktionel impotens |
US5562917A (en) | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
US5624677A (en) * | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
US5888534A (en) | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
US5688499A (en) | 1996-03-13 | 1997-11-18 | Queen's University At Kingston | Antagonism of endothelin actions |
DE19652268C2 (de) | 1996-12-16 | 2000-06-29 | Lohmann Therapie Syst Lts | Arzneizubereitung für die Freisetzung von Apomorphin in der Mundhöhle |
-
1998
- 1998-12-17 US US09/213,567 patent/US6291471B1/en not_active Expired - Fee Related
-
1999
- 1999-12-13 EP EP99966147A patent/EP1140094A1/fr not_active Withdrawn
- 1999-12-13 TR TR2001/01719T patent/TR200101719T2/xx unknown
- 1999-12-13 CZ CZ20012084A patent/CZ20012084A3/cs unknown
- 1999-12-13 KR KR1020017007500A patent/KR20010101241A/ko not_active Application Discontinuation
- 1999-12-13 JP JP2000587777A patent/JP2003521462A/ja not_active Withdrawn
- 1999-12-13 BR BR9916114-1A patent/BR9916114A/pt not_active IP Right Cessation
- 1999-12-13 AU AU21758/00A patent/AU2175800A/en not_active Abandoned
- 1999-12-13 HU HU0201618A patent/HUP0201618A3/hu unknown
- 1999-12-13 CA CA002354601A patent/CA2354601A1/fr not_active Abandoned
- 1999-12-13 NZ NZ511790A patent/NZ511790A/en unknown
- 1999-12-13 PL PL99354920A patent/PL354920A1/xx not_active Application Discontinuation
- 1999-12-13 IL IL14341099A patent/IL143410A0/xx unknown
- 1999-12-13 SK SK826-2001A patent/SK8262001A3/sk unknown
- 1999-12-13 CN CN99814559A patent/CN1335772A/zh active Pending
- 1999-12-13 WO PCT/US1999/029449 patent/WO2000035457A1/fr not_active Application Discontinuation
- 1999-12-17 AR ARP990106551A patent/AR021912A1/es not_active Application Discontinuation
-
2000
- 2000-01-11 TW TW088122257A patent/TW577740B/zh not_active IP Right Cessation
-
2001
- 2001-05-21 ZA ZA200104146A patent/ZA200104146B/xx unknown
- 2001-06-15 NO NO20012985A patent/NO20012985L/no not_active Application Discontinuation
- 2001-07-03 BG BG105664A patent/BG105664A/xx unknown
-
2002
- 2002-03-28 HK HK02102415.1A patent/HK1043303A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
TR200101719T2 (tr) | 2002-08-21 |
EP1140094A1 (fr) | 2001-10-10 |
NZ511790A (en) | 2004-04-30 |
NO20012985L (no) | 2001-08-16 |
SK8262001A3 (en) | 2002-01-07 |
BG105664A (en) | 2002-02-28 |
WO2000035457A1 (fr) | 2000-06-22 |
BR9916114A (pt) | 2003-01-14 |
HUP0201618A2 (en) | 2002-09-28 |
CZ20012084A3 (cs) | 2002-01-16 |
JP2003521462A (ja) | 2003-07-15 |
TW577740B (en) | 2004-03-01 |
AR021912A1 (es) | 2002-09-04 |
PL354920A1 (en) | 2004-03-22 |
CN1335772A (zh) | 2002-02-13 |
HUP0201618A3 (en) | 2003-03-28 |
CA2354601A1 (fr) | 2000-06-22 |
HK1043303A1 (zh) | 2002-09-13 |
IL143410A0 (en) | 2002-04-21 |
AU2175800A (en) | 2000-07-03 |
KR20010101241A (ko) | 2001-11-14 |
US6291471B1 (en) | 2001-09-18 |
NO20012985D0 (no) | 2001-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200104146B (en) | Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males. | |
GC0000096A (en) | Treatment of female sexual dysfunction. | |
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
IS2494B (is) | Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni | |
FI972205A0 (fi) | cGmp-PDE:n estäjiä erektiohäiriön hoidossa | |
AU4583899A (en) | Nasal administration of sildenafil for the treatment of erectile dysfunction | |
HK1051690A1 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain. | |
ZA9811507B (en) | Combination effective for the treatment of impotence. | |
AU2001274649A1 (en) | Topical preparation of alprostadil for the treatment of erectile dysfunction | |
HK1051692A1 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain. | |
AU6605800A (en) | Melanocortin receptor-3 ligands to treat sexual dysfunction | |
ZA200107736B (en) | Improved cancer treatment with temozolomide. | |
AU4676099A (en) | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction | |
AU7652400A (en) | Novel combination for the treatment of sexual dysfunction | |
IL154215A0 (en) | Medicine for fighting against sexual dysfunction | |
GB9917346D0 (en) | Medicament for treating premature ejaculation | |
ZA200204156B (en) | Water treatment. | |
ITRM990309A0 (it) | Composizione per il trattamento del prurito uremico e di forme di prurito non riconducibili a lesioni organiche. | |
ZA200203069B (en) | Peptides for treatment of erectile dysfunction. | |
AU2001237379A1 (en) | Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction | |
GB9904252D0 (en) | Composition for the treatment of pain | |
ZA991676B (en) | A device for use in the treatment of erectile dysfunction. | |
SI1173178T1 (sl) | Sestavek, ki obsega apomorfin in seldenafil, in njegova uporaba za zdravljenje erektilne disfunkcije | |
AU6676100A (en) | Improved treatment for acute physical insult to the central nervous system | |
SI1047428T1 (sl) | Uporaba morfolinola za zdravljenje seksualne disfunkcije |